Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial

  • T. Morgan
  • I. Awad
  • P. Keyl
  • K. Lane
  • D. Hanley
Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 105)



Brain hemorrhage is the most frequent fatal form of stroke and has the highest level of morbidity of any stroke subtype. For patients with both intracerebral hemorrhage and intraventricular hemorrhage (IVH), expected mortality is 50-80%. No validated, efficacious treatment exists for humans, but animal models demonstrate substantial physiologic and functional benefits associated with rapid, near-complete removal of blood from either the ventricle or intracerebral location (i.e., ~80% removal over 48 h). The purpose of the CLEAR-IVH trial (Parts A and B) is to evaluate safety and efficacy of using multiple injections of low-dose rt-PA to accelerate lysis and evacuation of IVH.


Patients enrolled in the trial receive an injection of 1.0mg rt-PA through an external ventricular drain every 8 h up to 12 doses, or until clot reduction or clinical endpoint is met. CT scans are taken daily to monitor clot resolution and check for unexpected bleeding events. In a previous dose-finding study where the safety profile (symptomatic re-bleeding) was 0%, 1 mg rt-PA every 8 h was determined the appropriate dose.


Comprehensive analyses of 36 patients in the recently completed CLEAR-IVH Part B are currently being conducted. Adverse events are within safety limits, including 30-day mortality, 8%; symptomatic re-bleeding, 8%; and bacterial ventriculitis, 0%.


Preliminary analyses show that use of low-dose rt-PA can be safely administered to stable IVH clots and may increase lysis rates.


Intraventricular hemorrhage thrombolysis tissue plas-minogen activator. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adams HP, Torner JC, Kassell NF (1992) Intraventricular hemorrhage among patients with recently ruptured aneurysms: a report of the Cooperative Aneurysm Study. Stroke 23: 140 (abstract)Google Scholar
  2. 2.
    Adams RE, Diringer MN (1998) Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydroceph-alus. Neurology 50: 519–523PubMedGoogle Scholar
  3. 3.
    Ahmann PA, Lazzara A, Dykes FD, Brann AW Jr, Schwartz JF (1980) Intraventricular hemorrhage in the high-risk preterm infant: incidence and outcome. Ann Neurol 7: 118–124PubMedCrossRefGoogle Scholar
  4. 4.
    Bagley C (1928) Blood in cerebrospinal fluid. Resultant functional and organic alterations in the central nervous system. Arch Surg 17: 39–81Google Scholar
  5. 5.
    Broderick JP, Brott T, Tomsick T, Miller R, Huster G (1993) Intracerebral hemorrhage more than twice as common as subarach-noid hemorrhage. J Neurosurg 78: 188–191PubMedGoogle Scholar
  6. 6.
    Brott T, Thalinger K, Hertzberg V (1986) Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 17: 1078–1083PubMedGoogle Scholar
  7. 7.
    Conway JE, Oshiro EM, Piantadosi S (1998) Ventricular blood is an admission ct variable which predicts poor clinical outcome after aneurysmal subarachnoid hemorrhage. American Association of Neurological Surgeons Annual Meeting, Philadelphia, PA. J Neurosurg 88: 398A (abstract)Google Scholar
  8. 8.
    Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after spontaneous intracerebral hemorrahge. A prospective study of 166 cases using multivariate analysis. Stroke 22: 1–6PubMedGoogle Scholar
  9. 9.
    DeLand FH, James AE Jr, Ladd DJ, Konigsmark BW (1972) Normal pressure hydrocephalus: a histologic study. Am J Clin Pathol 58: 58–63PubMedGoogle Scholar
  10. 10.
    Ellington E, Margolis G (1969) Block of arachnoid villus by subarachnoid hemorrhage. J Neurosurg 30: 651–657PubMedGoogle Scholar
  11. 11.
    Findlay JM, Weir BK, Gordon P, Grace M, Baughman R (1989) Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24: 491–498PubMedCrossRefGoogle Scholar
  12. 12.
    Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1–9PubMedCrossRefGoogle Scholar
  13. 13.
    Kassell NF, Torner JC, Adams HP Jr (1984) Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 61: 225–230PubMedCrossRefGoogle Scholar
  14. 14.
    Kibler RF, Couch RS, Crompton MR (1961) Hydrocephalus in the adult following spontaneous subarachnoid hemorrhage. Brain 84: 45–61PubMedCrossRefGoogle Scholar
  15. 15.
    Lisk DR, Pasteur W, Rhoades H, Putnam RD, Grotta JC (1994) Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 44: 133–139PubMedCrossRefGoogle Scholar
  16. 16.
    Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Küker W, Gilsbach JM (1997) Ventricular dilatation in experimental intra-ventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke 28: 141–148PubMedGoogle Scholar
  17. 17.
    Mohr G, Ferguson G, Khan M, Malloy D, Watts R, Benoit B, Weir B (1983) Intraventricular hemorrhage from ruptured aneurysm. J Neurosurg 58: 482–487PubMedGoogle Scholar
  18. 18.
    Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: Part 1. Canine intraventricular blood cast model. Neurosurgery 19: 540–546PubMedGoogle Scholar
  19. 19.
    Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: Part 2. In vivo safety study of intraventricular urokinase. Neurosurgery 19: 547–552PubMedGoogle Scholar
  20. 20.
    Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19: 553–572PubMedCrossRefGoogle Scholar
  21. 21.
    Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 g. J Pediatr 92: 529–534PubMedCrossRefGoogle Scholar
  22. 22.
    Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Hier DB, Kase CS (1991) Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol 29: 658–663PubMedCrossRefGoogle Scholar
  23. 23.
    Tuhrim S, Horowitz DR, Sacher M, Godbold JH (1995) Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med 23: 950–954PubMedCrossRefGoogle Scholar
  24. 24.
    Yasargil MG, Yonekawa Y, Zumstein B, Stahl HJ (1973) Hydrocephalus following spontaneous subarachnoid hemorrhage. Clinical features and treatment. J Neurosurg 39: 474–479PubMedGoogle Scholar
  25. 25.
    Young WB, Lee KP, Pessin MS, Kwan ES, Rand WM, Caplan LR (1990) Prognostic significance of ventricular blood in supratentorial hemorrhage: a volumetric study. Neurology 40: 616–619PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • T. Morgan
    • 1
  • I. Awad
    • 2
  • P. Keyl
    • 3
  • K. Lane
    • 1
  • D. Hanley
    • 1
  1. 1.The Johns Hopkins UniversityBaltimoreUSA
  2. 2.Evanston Northwestern UniversityEvanstonUSA
  3. 3.Keyl AssociatesEast SandwichUSA

Personalised recommendations